PT  - JOURNAL ARTICLE
AU  - Hoyle, Brian
ED  - Koren, Michael J.
TI  - Tolvaptan Did Not Reduce Hospital Stay for Hyponatremia
DP  - 2014 Nov 01
TA  - MD Conference Express
PG  - 8--9
VI  - 14
IP  - 20
4099  - http://mdc.sagepub.com/content/14/20/8.short
4100  - http://mdc.sagepub.com/content/14/20/8.full
AB  - Hyponatremia is the most common clinically encountered serum electrolyte abnormality, occurring in 7% to 8% of elderly, ambulatory patients and 15% to 20% of hospitalized patients [Huda MS et al. Postgrad Med J 2006]. This article reports on a prospective clinical trial that evaluated the effect of the selective, competitive vasopressin 2 antagonist tolvaptan in the treatment of hyponatremia [Koren MJ et al. ICE ENDO 2014 (poster LBSA-0737)].